Matter-Walstra, K; Schwenkglenks, Matthias; Dedes, K J (2017). Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting. Breast Cancer Research and Treatment, 163(3):635.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
04 Faculty of Medicine > University Hospital Zurich > Clinic for Gynecology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Oncology
Life Sciences > Cancer Research |
| Language: | English |
| Date: | June 2017 |
| Deposited On: | 04 Jan 2018 08:34 |
| Last Modified: | 14 Aug 2022 07:28 |
| Publisher: | Springer |
| ISSN: | 0167-6806 |
| OA Status: | Closed |
| Publisher DOI: | https://doi.org/10.1007/s10549-017-4209-5 |
| PubMed ID: | 28321586 |
Matter-Walstra, K